(For a live blog on the U.S. stock market, click or type LIVE/ in a news window.)
* Doctors to weigh if Trump can leave hospital Monday - Trump aide
* Regeneron jumps as Trump takes dose of its dual antibody
* MyoKardia surges on takeover deal with Bristol-Myers
* Service sector activity rises above pre-pandemic level
* Indexes up: Dow 1.30%, S&P 1.37%, Nasdaq 1.70% (Adds comments, updates prices)
Oct 5 (Reuters) - Wall Street’s main indexes jumped on Monday, recovering from a sharp fall in the previous session as hints President Donald Trump could return to the White House and hopes of a new fiscal stimulus bill lifted sentiment.
Although Trump’s medical condition remained unclear as he began a fourth day at the military hospital where he is being treated for COVID-19, his doctors have said he could be discharged as soon as Monday.
Ten of the 11 major S&P indexes were up, with energy , the worst performing sector this year, rising 1.7%. Materials and financials were also among the biggest gainers in morning trading.
Shares of Regeneron Pharmaceuticals Inc jumped 6.1% after Trump’s physician said he had been treated with an intravenous dose of Regeneron’s dual antibody treatment. The wider healthcare index added 1.7%.
“One of his treatments was an experimental drug from Regeneron (and) that’s showing that this could be a major component to treatments moving forward for people,” said Thomas Hayes, chairman at Great Hill Capital LLC in New York.
Doubts about the scale of further fiscal aid and a slowing economic recovery have weighed on the S&P 500 recently, with the benchmark index in September logging its worst month since the coronavirus-driven crash earlier this year.
But latest data showed the services industry’s activity picked up in September, pulling above a level that prevailed before the pandemic struck the United States.
Further aiding the mood, White House Chief of Staff Mark Meadows said there was still potential to reach agreement with U.S. lawmakers on more coronavirus relief and that Trump was committed to getting the deal done.
“The market has really traded on stimulus news, both to the high side and to the low side over the past few months,” said Ross Mayfield, investment strategy analyst at Baird.
“The need for that stimulus is becoming more and more evident. While it might boost markets a little bit, the real economy is showing that it’s necessary to really take this recovery up another level.”
At 11:32 a.m. ET, the Dow Jones Industrial Average was up 1.30%, the S&P 500 was up 1.37% and the Nasdaq Composite was up 1.70%.
Heavyweight tech-related stocks including Apple Inc , Nvidia Corp, Amazon.com Inc and Microsoft Corp were up between 1.4% and 2.2% after weighing heavily on the Nasdaq on Friday.
The S&P banking subindex rose 1.8% as the U.S. Treasury 30-year yield hit its highest since late August.
Real estate - considered a defensive play - was the only S&P sector in the red.
MyoKardia Inc surged 58.0% after Bristol-Myers Squibb Co said it would buy the company for about $13 billion. Shares of Bristol-Myers rose 0.7%.
Advancing issues outnumbered decliners more than 3-to-1 on the NYSE and the Nasdaq.
The S&P index recorded 22 new 52-week highs and no new low, while the Nasdaq recorded 88 new highs and seven new lows. (Reporting by Devik Jain and Sagarika Jaisinghani in Bengaluru; editing by Patrick Graham and Maju Samuel)
Nuestros Estándares: Los principios Thomson Reuters.